Current Challenges and Issues in Indian Regulations of Medical Devices

Title:Current Challenges and Issues in Indian Regulations of Medical Devices

Volume: 19 Issue: 5

Author(s): Rohit Bhatia, Shubham Singh, Ananya Parashar and Arti R. Thakkar*

Affiliation:

• Amity Institute of Pharmacy, Amity University Uttar Pradesh (AUUP), Sector 125, Noida 201303, Uttar Pradesh, India

Keywords: Central drugs standard control organization (CDSCO), medical device regulation (MDR), issues, challenges, quality management system, materiovigilance.

Abstract: The study's objectives are to highlight the significance of medical devices, investigate the prospective expansion of the Indian market, look at the legislative changes made possible by MDR 2020, and deal with the ongoing issues with cost, quality, and adverse responses. The research aims to enhance the Indian medical devices sector by offering insightful observations and suggestions. This study intends to highlight the significance of medical devices, assess the prospective growth of the Indian industry, look at the regulatory changes brought about by MDR 2020, and address the ongoing issues with cost, quality, and adverse responses. The goal of the research is to help the Indian medical devices business grow by offering helpful insights and practical suggestions. The improvement of people's well-being and health depends heavily on medical technologies. The usage of medical devices is expected to rise as technology develops and illnesses spread. The Indian medical device industry is expected to grow to a market value of USD 50 billion by 2025, placing it fourth in Asia. The "Atma Nibbar Bharat" strategy, which emphasizes independence, is anticipated to support the expansion of India's medical device industry. Before the passage of the Medications and Cosmetics Act of 1940, there were no explicit regulations controlling medical devices, which resulted in their designation as medications. The Medical Device Regulation (MDR) was initially announced in 2017, nevertheless, and went into effect in January 2018. The Indian medical device sector was greatly impacted by the change of this guideline paper into MDR 2020. For testing and altering equipment that comes within the new criteria, the amended legislation offers a wider range of options. Despite these positive adjustments, problems still exist. Significant drawbacks include unregulated pricing, difficulties with quality control, and negative responses to medical equipment. This essay covers these topics in extensive detail and includes pertinent advice. It is stated which department is in control of handling these issues. To successfully address these issues, thorough examples, case studies, and solutions are given. In conclusion, this abstract emphasizes the significance of medical devices, the market's potential for growth in India, MDR 2020's legislative adjustments, as well as the ongoing difficulties related to cost, quality, and bad responses. The essay seeks to solve these problems by providing insightful analysis and suggestions.

Cite this article as:

Bhatia Rohit, Singh Shubham, Parashar Ananya and Thakkar R. Arti*, Current Challenges and Issues in Indian Regulations of Medical Devices, Current Drug Therapy 2024; 19 (5) . https://dx.doi.org/10.2174/1574885519666230912121853